|
GS866: Linear decrease in expression in both Pax6 (Sey) mutants and controls.
|
|
GS183848: GO:0044260 cellular macromolecule metabolic process
|
|
GS136852: Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 3 (Tmevd3, Published QTL Chr 14)
|
|
GS136223: mandible length 15 (Manln15, Published QTL Chr 14)
|
|
GS34341: Hippocampus Gene expression correlates of Cocaine Open Field TOTAL rears in Males BXD
|
|
GS183803: GO:0044267 cellular protein metabolic process
|
|
GS135743: dystrophic cardiac calcinosis 4 (Dyscalc4, Published QTL Chr 14)
|
|
GS135493: behavioral response to methamphetamines 9 (Brmth9, Published QTL Chr 14)
|
|
GS189020: GO:0016311 dephosphorylation
|
|
GS178461: GO:0009987 cellular process
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS182834: GO:0005623 cell
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS198370: GO:0042578 phosphoric ester hydrolase activity
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS178448: GO:0005634 nucleus
|
|
GS182474: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS199635: GO:0005622 intracellular
|
|
GS179830: GO:0006464 cellular protein modification process
|
|
GS127683: Alcohol consumption QTL 7 (Alc7, Published QTL, Chr 16)
|
|
GS193268: GO:0005575 cellular_component
|
|
GS213076: Genes with suggestive difference in (B6) vs (B6PF1 + PB6F1 + PWD) comparison
|
|
GS136627: Stem cell proliferation 9 (Scpro9, Published QTL Chr 14)
|
|
GS136961: weight adult 3 (Wta3, Published QTL Chr 14)
|
|
GS178819: GO:0016791 phosphatase activity
|
|
GS208043: GO:0016788 hydrolase activity, acting on ester bonds
|
|
GS199634: GO:0005623 cell
|
|
GS205610: GO:0044430 cytoskeletal part
|
|
GS204290: GO:0004721 phosphoprotein phosphatase activity
|
|
GS201256: GO:0044422 organelle part
|
|
GS192691: GO:0015630 microtubule cytoskeleton
|
|
GS34833: Hippocampus Gene expression correlates of Open Field Inovel TOTAL rears in the center in Females BXD
|
|
GS187426: GO:0004721 phosphoprotein phosphatase activity
|
|
GS34828: Hippocampus Gene expression correlates of Open Field Inovel TOTAL rears in the center in Females & Males BXD
|
|
GS184814: GO:0005874 microtubule
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS187422: GO:0004725 protein tyrosine phosphatase activity
|
|
GS213077: Genes with suggestive difference in (PWD) vs (PB6F1 + B6PF1 + B6) comparison
|
|
GS136040: insulin dependent diabetes susceptibility 12 (Idd12, Published QTL Chr 14)
|
|
GS184452: GO:0044422 organelle part
|
|
GS184566: GO:0019538 protein metabolic process
|
|
GS191106: GO:0044464 cell part
|
|
GS191954: GO:0005856 cytoskeleton
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS199267: GO:0043234 protein complex
|
|
GS84276: nicotine sensitivity (Published QTL, Chr 14)
|
|
GS208893: GO:0005856 cytoskeleton
|
|
GS34404: Hippocampus Gene expression correlates of Novel environment rears 30-45 min in the center in Females BXD
|
|
GS201251: GO:0044424 intracellular part
|
|
GS36003: Hippocampus Gene expression correlates of Open Field Inovel TOTAL rears in the center in Females & Males BXD
|
|
GS84272: METH responses for body temperature (Published QTL, Chr 14)
|
|
GS193059: GO:0044446 intracellular organelle part
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS129166: plasma plant sterol 1 (Plast1 Published QTL Chr 14)
|
|
GS191135: GO:0016788 hydrolase activity, acting on ester bonds
|
|
GS192296: GO:0006796 phosphate-containing compound metabolic process
|
|
GS84271: METH responses for chewing (Published QTL, Chr 14)
|
|
GS195576: GO:0016791 phosphatase activity
|
|
GS34083: Hippocampus Gene expression correlates of Open Field rears 30-45 min post cocaine in Males BXD
|
|
GS201626: GO:0005874 microtubule
|
|
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS136949: white blood cell quantitative locus 6 (Wbcq6, Published QTL Chr 14)
|
|
GS208037: GO:0016787 hydrolase activity
|
|
GS181578: GO:0042578 phosphoric ester hydrolase activity
|
|
GS129167: plasma plant sterol 1a (Plast1a Published QTL Chr 14)
|
|
GS184447: GO:0044424 intracellular part
|
|
GS213073: Genes with suggestive difference in (PB6F1) vs (B6PF1 + B6 + PWD) comparison
|
|
GS208302: GO:0005815 microtubule organizing center
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS182469: GO:0043234 protein complex
|
|
GS135452: bone length and organs 8 (Bod8, Published QTL Chr 14)
|
|
GS177598: GO:0043412 macromolecule modification
|
|
GS188751: GO:0044430 cytoskeletal part
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS84274: METH responses for home cage activity (Published QTL, Chr 14)
|
|
GS180164: GO:0008150 biological_process
|
|
GS136049: insulin dependent diabetes susceptibility 8 (Idd8, Published QTL Chr 14)
|
|
GS177531: GO:0043170 macromolecule metabolic process
|
|
GS36580: Hippocampus Gene expression correlates of Novel Open Field Number of urinations in Males BXD
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS34394: Hippocampus Gene expression correlates of Novel environment rears 15-30 min in the center in Females BXD
|
|
GS180236: GO:0032991 macromolecular complex
|
|
GS182234: GO:0036211 protein modification process
|
|
GS208012: GO:0044464 cell part
|
|
GS84275: cocaine seizure (Published QTL, Chr 14)
|
|
GS210212: GO:0005575 cellular_component
|
|
GS136279: modifier of ocular retardation 2 (Modor2, Published QTL Chr 14)
|
|
GS84273: METH responses for home cage activity (Published QTL, Chr 14)
|
|
GS204286: GO:0004725 protein tyrosine phosphatase activity
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS136224: mandible length 16 (Manln16, Published QTL Chr 14)
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS136597: resistance to thymic deletion 3 (Rthyd3, Published QTL Chr 14)
|
|
GS203594: GO:0043226 organelle
|
|
GS197892: GO:0043228 non-membrane-bounded organelle
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS192299: GO:0006793 phosphorus metabolic process
|
|
GS186744: GO:0043226 organelle
|
|
GS182835: GO:0005622 intracellular
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS181102: GO:0043228 non-membrane-bounded organelle
|
|
GS213074: Genes with suggestive difference in (B6PF1) vs (PB6F1 + B6 + PWD) comparison
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS194087: GO:0003674 molecular_function
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS128035: Alcohol consumption QTL 13 (Alc13, Published QTL, Chr 16)
|
|
GS177356: GO:0003674 molecular_function
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS191129: GO:0016787 hydrolase activity
|
|
GS195199: GO:0005634 nucleus
|
|
GS136712: susceptibility to lung cancer 13 (Sluc13, Published QTL Chr 14)
|
|
GS180166: GO:0008152 metabolic process
|
|
GS36008: Hippocampus Gene expression correlates of Open Field Inovel TOTAL rears in the center in Females BXD
|
|
GS209634: GO:0015630 microtubule cytoskeleton
|
|
GS184129: GO:0006470 protein dephosphorylation
|
|
GS128036: Alcohol consumption QTL 11 (Alc11, Published QTL, Chr 16)
|
|
GS135777: epistatic circling SWR/J (ecs, Published QTL Chr 14)
|